Records containing: Neuroendocrine Tumors

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-02-20
Phase 1 Trial of PARP Inhibitor Combined With 177Lu-DOTA-Octreotate Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Metastatic NeuroEndocrine Tumor
CLINICAL_TRIALS study record update · 2025-02-19
Clinical Use of a J-PET Scanner Prototype Made of Plastic Scintilators
CLINICAL_TRIALS study record update · 2025-02-12
Evaluation of Preoperative Imaging (CT Scan, DOPA-PET and DOTATOC) in Patients With Small Bowel Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2025-02-12
Positron Emission Tomography Imaging of Participants With Known or Suspected Neuroendocrine Tumours Using 64Cu SARTATE: A Multi-Centre, Single Arm, Non-Randomised, Blinded-Review, Phase II Study
CLINICAL_TRIALS study record update · 2025-02-12
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-02-10
Neuroendocrine and Adrenal Tumors: Biochemical, Histopathologic and Genetic Studies
CLINICAL_TRIALS study record update · 2025-02-06
Dual-Tracer Theranostic PET
CLINICAL_TRIALS study record update · 2025-02-04
Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2025-01-31
Phase II Trial of Cabozantinib in Combination With Nivolumab for Advanced Carcinoid Tumors
CLINICAL_TRIALS study record update · 2025-01-29
Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study
CLINICAL_TRIALS study record update · 2025-01-28
Prospective Observational Study to Assess the Effectiveness and Safety of Lanreotide Autogel® in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Asia Region
CLINICAL_TRIALS study record update · 2025-01-13
Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2025-01-13
A Phase II Study of Platinum-doublet Chemotherapy in Combination With Nivolumab as First-line Treatment in Subjects With Unresectable, Locally Advanced or Metastatic G3 Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
CLINICAL_TRIALS study record update · 2025-01-13
Peptide Receptor Radionuclide Therapy (PRRT) with Radiolabelled Somatostatin Analogue 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors, 18F-2-fluoro-2-deoxy-D-glucose (FDG)-PET Negative Patients: a Prospective Phase II Randomized Study
CLINICAL_TRIALS study record update · 2025-01-10
An Exploratory Study of 3-[18F]Fluoro-para-hydroxyphenethylguanidine ([18F]3F-PHPG) in Patients With Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2025-01-09
A Phase II Study of Durvalumab (MEDI4736) Plus Tremelimumab for the Treatment of Patients With Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (the DUNE Trial)
CLINICAL_TRIALS study record update · 2025-01-08
A Phase II, Single-arm, Multicenter Clinical Study of Adebrelimab Combined With Chemotherapy and Apatinib as First-line Treatment for Unresectable Locally Advanced or Metastatic Pulmonary Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2025-01-06
A Prospective, Multicentric, Proof-of-concept Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment
CLINICAL_TRIALS study record update · 2024-12-24
A Phase II Study of Avelumab in Unresectable/Metastatic, Progressive Grade 2-3 Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2024-12-18
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
CLINICAL_TRIALS study record update · 2024-12-03
Study of Recombinant Adenovirus (AdVince) in Patients With Neuroendocrine Tumors; Safety and Efficacy
CLINICAL_TRIALS study record update · 2024-11-18
An Italian Multicenter Phase II Trial of Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
CLINICAL_TRIALS study record update · 2024-11-15
A Phase 1/2a, Multicenter, Open-Label, Dose-Escalation and Expansion Study of Intravenously Administered 23ME-00610 in Patients With Advanced Solid Malignancies
CLINICAL_TRIALS study record update · 2024-10-15
A Real-world Study to Explore and Evaluate Individualized Targeted Agents for Patients of Digestive Cancers Based on Molecular Characteristics After Standard Therapy Failure in China
CLINICAL_TRIALS study record update · 2024-10-15
Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors